Building upon groundbreaking research demonstrating how the SARS-CoV-2 virus disrupts mitochondrial function in multiple organs, researchers from Children's Hospital of Philadelphia (CHOP) demonstrated that mitochondrially-targeted antioxidants could reduce the effects of the virus while avoiding viral gene mutation resistance, a strategy that may...
Preclinical data suggest antioxidant strategy to address mitochondrial dysfunction caused by SARS-CoV-2 virus retrieved 15 July 2024 from https://medicalxpress.com/news/2024-07-preclinical-antioxidant-strategy-mitochondrial-dysfunction.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.57 minutes agoUse this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study reveals early immune responses to SARS-CoV-2, offering insights for future COVID-19 treatmentsResearchers analyzed early immune responses to SARS-CoV-2 using single-cell multi-omics, revealing key cellular states associated with different infection outcomes.
Read more »
How does SARS-CoV-2 cause lymphopenia when T cells barely express ACE-2 receptors?Researchers reveal both direct and indirect mechanisms of SARS-CoV-2-induced lymphopenia, highlighting the role of CD147 and alternative viral entry routes into T cells.
Read more »
Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibitionHIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide.
Read more »
Tufts' new ingestible microbiome sampling pill completes preclinical trialsSignificant progress has been made at Tufts University School of Engineering in the development of a small device, about the size of a vitamin pill, that can be swallowed and passed through the gastrointestinal tract to sample the full inventory of microorganisms in an individual's gastro-intestinal tract.
Read more »
Antibody-drug conjugate shows preclinical efficacyA new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, 'Entering the golden age for antibody-drug conjugates in gynecologic cancer.'
Read more »
Novel genome editing approach restores hearing in adult preclinical models with genetic deafnessMass Eye and Ear researchers restored hearing in preclinical mouse models with a specific form of inherited deafness called DFNA50 caused by mutations in microRNA, by using a novel in vivo CRISPR genome editing approach.
Read more »